Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment

Purpose. To compare phacocanaloplasty (PC) and phaco-non-penetrating deep sclerectomy (PDS). Methods. 75 patients with uncontrolled glaucoma and cataract were randomized for PC (37 eyes) or PDS (38 eyes). Intraocular pressure (IOP) and number of medications (meds) were prospectively evaluated. Follo...

Full description

Bibliographic Details
Main Authors: Anna Byszewska, Anselm Jünemann, Marek Rękas
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2018/2347593
id doaj-34b556f3ada34d049f7e0f4b2d42901e
record_format Article
spelling doaj-34b556f3ada34d049f7e0f4b2d42901e2020-11-24T23:12:03ZengHindawi LimitedJournal of Ophthalmology2090-004X2090-00582018-01-01201810.1155/2018/23475932347593Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life AssessmentAnna Byszewska0Anselm Jünemann1Marek Rękas2Department of Ophthalmology, Military Institute of Medicine, Warsaw, PolandDepartment of Ophthalmology, University Eye Hospital, Rostock, GermanyDepartment of Ophthalmology, Military Institute of Medicine, Warsaw, PolandPurpose. To compare phacocanaloplasty (PC) and phaco-non-penetrating deep sclerectomy (PDS). Methods. 75 patients with uncontrolled glaucoma and cataract were randomized for PC (37 eyes) or PDS (38 eyes). Intraocular pressure (IOP) and number of medications (meds) were prospectively evaluated. Follow-up examinations were performed on days 1 and 7 and after 1, 3, 6, 12, 18, and 24 months. Surgical success was calculated. Complications and postoperative interventions were noted. Quality of life (QoL) was analyzed. Results. Preoperatively, mean IOP and meds were comparable (P>0.05). After 24 months, IOP significantly decreased in PC from 19.4 ± 5.9 mmHg (2.6 ± 0.9 meds) to 13.8 ± 3.3 mmHg (0.5 ± 0.9 meds) and in PDS from 19.7 ± 5.4 mmHg (2.9 ± 0.9 meds) to 15.1 ± 2.9 mmHg (1.1 ± 1.2 meds). Statistically lower IOP was observed in PC in the 6th month and persisted until 24 months (P<0.05). No difference was found in meds (except for month 18, in which less drugs were used in PC (P=0.001)) or success rates (P>0.05). The most frequent complication in PC was transient hyphema (46%), in PDS bleb fibrosis (24%). PC patients during postoperative period required only goniopuncture (22% of subjects), whereas PDS patients required, in order to maintain subconjuctival outflow, subconjunctival 5-fluorouracil injections in 95% of cases (median = 3), suture lysis (34%), needling (24%), and goniopuncture (37%). NEI VFQ-25 mean composite score for PC was 78.04 ± 24.36 points and for PDS 74.29 ± 24.45 (P=0.136). α Cronbach’s correlation coefficient was 0.913. Conclusions. PC leads to a more effective decrease in IOP than PDS in midterm observation with similar safety profiles. PDS patients required a vast number of additional procedures in contrast to PC patients, but this fact did not influence QoL.http://dx.doi.org/10.1155/2018/2347593
collection DOAJ
language English
format Article
sources DOAJ
author Anna Byszewska
Anselm Jünemann
Marek Rękas
spellingShingle Anna Byszewska
Anselm Jünemann
Marek Rękas
Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment
Journal of Ophthalmology
author_facet Anna Byszewska
Anselm Jünemann
Marek Rękas
author_sort Anna Byszewska
title Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment
title_short Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment
title_full Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment
title_fullStr Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment
title_full_unstemmed Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2-Year Results and Quality of Life Assessment
title_sort canaloplasty versus nonpenetrating deep sclerectomy: 2-year results and quality of life assessment
publisher Hindawi Limited
series Journal of Ophthalmology
issn 2090-004X
2090-0058
publishDate 2018-01-01
description Purpose. To compare phacocanaloplasty (PC) and phaco-non-penetrating deep sclerectomy (PDS). Methods. 75 patients with uncontrolled glaucoma and cataract were randomized for PC (37 eyes) or PDS (38 eyes). Intraocular pressure (IOP) and number of medications (meds) were prospectively evaluated. Follow-up examinations were performed on days 1 and 7 and after 1, 3, 6, 12, 18, and 24 months. Surgical success was calculated. Complications and postoperative interventions were noted. Quality of life (QoL) was analyzed. Results. Preoperatively, mean IOP and meds were comparable (P>0.05). After 24 months, IOP significantly decreased in PC from 19.4 ± 5.9 mmHg (2.6 ± 0.9 meds) to 13.8 ± 3.3 mmHg (0.5 ± 0.9 meds) and in PDS from 19.7 ± 5.4 mmHg (2.9 ± 0.9 meds) to 15.1 ± 2.9 mmHg (1.1 ± 1.2 meds). Statistically lower IOP was observed in PC in the 6th month and persisted until 24 months (P<0.05). No difference was found in meds (except for month 18, in which less drugs were used in PC (P=0.001)) or success rates (P>0.05). The most frequent complication in PC was transient hyphema (46%), in PDS bleb fibrosis (24%). PC patients during postoperative period required only goniopuncture (22% of subjects), whereas PDS patients required, in order to maintain subconjuctival outflow, subconjunctival 5-fluorouracil injections in 95% of cases (median = 3), suture lysis (34%), needling (24%), and goniopuncture (37%). NEI VFQ-25 mean composite score for PC was 78.04 ± 24.36 points and for PDS 74.29 ± 24.45 (P=0.136). α Cronbach’s correlation coefficient was 0.913. Conclusions. PC leads to a more effective decrease in IOP than PDS in midterm observation with similar safety profiles. PDS patients required a vast number of additional procedures in contrast to PC patients, but this fact did not influence QoL.
url http://dx.doi.org/10.1155/2018/2347593
work_keys_str_mv AT annabyszewska canaloplastyversusnonpenetratingdeepsclerectomy2yearresultsandqualityoflifeassessment
AT anselmjunemann canaloplastyversusnonpenetratingdeepsclerectomy2yearresultsandqualityoflifeassessment
AT marekrekas canaloplastyversusnonpenetratingdeepsclerectomy2yearresultsandqualityoflifeassessment
_version_ 1725602657793474560